109 related articles for article (PubMed ID: 8864450)
1. Increased plasma level of vascular endothelial glycoprotein thrombomodulin as an early indicator of endothelial damage in bone marrow transplantation.
Testa S; Manna A; Porcellini A; Maffi F; Morstabilini G; Denti N; Macchi S; Rosti G; Porcellini G; Cassi D; Ferrari L
Bone Marrow Transplant; 1996 Aug; 18(2):383-8. PubMed ID: 8864450
[TBL] [Abstract][Full Text] [Related]
2. Endothelium and bone marrow transplantation.
Catani L; Gugliotta L; Vianelli N; Nocentini F; Baravelli S; Bandini G; Cirio TM; Tura S
Bone Marrow Transplant; 1996 Feb; 17(2):277-80. PubMed ID: 8640179
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease.
Salat C; Holler E; Kolb HJ; Pihusch R; Reinhardt B; Hiller E
Bone Marrow Transplant; 1997 May; 19(9):909-14. PubMed ID: 9156265
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial lesion in patients undergoing bone marrow transplantation.
Richard S; Seigneur M; Blann A; Adams R; Renard M; Puntous M; Boiron JM; Amiral J; Reiffers J; Boisseau M
Bone Marrow Transplant; 1996 Nov; 18(5):955-9. PubMed ID: 8932851
[TBL] [Abstract][Full Text] [Related]
5. Markers of endothelial function in pediatric stem cell transplantation for acute leukemia.
Luzzatto G; Cella G; Messina C; Randi ML; Sbarai A; Zanesco L
Med Pediatr Oncol; 2003 Jan; 40(1):9-12. PubMed ID: 12426679
[TBL] [Abstract][Full Text] [Related]
6. Early hemostatic alterations following bone marrow transplantation: a prospective study.
Vannucchi AM; Rafanelli D; Longo G; Bosi A; Guidi S; Saccardi R; Filimberti E; Cinotti S; Grossi A; Morfini M
Haematologica; 1994; 79(6):519-25. PubMed ID: 7896209
[TBL] [Abstract][Full Text] [Related]
7. Changes in protein C, factor VII and endothelial markers after autologous bone marrow transplantation: possible implications in the pathogenesis of veno-occlusive disease.
Bazarbachi A; Scrobohaci ML; Gisselbrecht C; Marolleau JP; Mansi A; Brice P; Gorra P; Drouet L
Nouv Rev Fr Hematol (1978); 1993 Apr; 35(2):135-40. PubMed ID: 8332449
[TBL] [Abstract][Full Text] [Related]
8. Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation.
Park YD; Yasui M; Yoshimoto T; Chayama K; Shimono T; Okamura T; Inoue M; Yumura-Yagi K; Kawa-Ha K
Bone Marrow Transplant; 1997 May; 19(9):915-20. PubMed ID: 9156266
[TBL] [Abstract][Full Text] [Related]
9. The levels of soluble P-selectin, von Willebrand factor and thrombomodulin in patients with neurological complications after allogeneic bone marrow transplantation.
Takatsuka H; Takemoto Y; Okamoto T; Fujimori Y; Suehiro A; Kakishita E; Kanamaru A
Bone Marrow Transplant; 1998 Apr; 21(8):809-13. PubMed ID: 9603405
[TBL] [Abstract][Full Text] [Related]
10. IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.
Ferrà C; de Sanjosé S; Gallardo D; Berlanga JJ; Rueda F; Marìn D; de la Banda E; Ancìn I; Peris J; Garcìa J; Grañena A
Haematologica; 1998 Dec; 83(12):1082-7. PubMed ID: 9949625
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality.
Schots R; Kaufman L; Van Riet I; Lacor P; Trullemans F; De Waele M; Van Camp B
Bone Marrow Transplant; 1998 Jul; 22(1):79-85. PubMed ID: 9678800
[TBL] [Abstract][Full Text] [Related]
12. Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications.
Ferrà C; de Sanjosé S; Lastra CF; Martí F; Mariño EL; Sureda A; Brunet S; Gallardo D; Berlanga JJ; García J; Grañena A
Bone Marrow Transplant; 1997 Dec; 20(12):1075-80. PubMed ID: 9466281
[TBL] [Abstract][Full Text] [Related]
13. Oral eicosapentaenoic acid for complications of bone marrow transplantation.
Takatsuka H; Takemoto Y; Iwata N; Suehiro A; Hamano T; Okamoto T; Kanamaru A; Kakishita E
Bone Marrow Transplant; 2001 Oct; 28(8):769-74. PubMed ID: 11781629
[TBL] [Abstract][Full Text] [Related]
14. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
Zeigler ZR; Rosenfeld CS; Andrews DF; Nemunaitis J; Raymond JM; Shadduck RK; Kramer RE; Gryn JF; Rintels PB; Besa EC; George JN
Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of hemostatic parameters in bone marrow transplant-associated thrombotic microangiopathy.
Kanamori H; Maruta A; Sasaki S; Yamazaki E; Ueda S; Katoh K; Tamura T; Otsuka-Aoba M; Taguchi J; Harano H; Ogawa K; Mohri H; Okubo T; Matsuzaki M; Watanabe S; Koharazawa H; Fujita H; Kodama F
Bone Marrow Transplant; 1998 Apr; 21(7):705-9. PubMed ID: 9578311
[TBL] [Abstract][Full Text] [Related]
16. Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study.
Lee JH; Lee KH; Kim S; Lee JS; Kim WK; Park CJ; Chi HS; Kim SH
Bone Marrow Transplant; 1998 Nov; 22(9):883-8. PubMed ID: 9827816
[TBL] [Abstract][Full Text] [Related]
17. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia.
Lee JH; Lee KH; Choi SJ; Min YJ; Kim JG; Kim S; Lee JS; Kim SH; Park CJ; Chi HS; Kim WK
Bone Marrow Transplant; 2000 Sep; 26(6):657-62. PubMed ID: 11041568
[TBL] [Abstract][Full Text] [Related]
18. Protein C, protein S and antithrombin III levels in the course of bone marrow and subsequent liver transplantation due to veno-occlusive disease.
Salat C; Holler E; Göhring P; Poley S; Kolb HJ; Pihusch R; Reinhardt B; Krämling HJ; Haller M; Hiller E
Eur J Med Res; 1996 Nov; 1(12):571-4. PubMed ID: 9438165
[TBL] [Abstract][Full Text] [Related]
19. Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications.
Nürnberger W; Michelmann I; Burdach S; Göbel U
Ann Hematol; 1998 Feb; 76(2):61-5. PubMed ID: 9540759
[TBL] [Abstract][Full Text] [Related]
20. Serum tumor marker CA 125 is an early and sensitive indicator of veno-occlusive disease in children undergoing bone marrow transplantation.
Petäjä J; Pitkänen S; Vettenranta K; Fasth A; Heikinheimo M
Clin Cancer Res; 2000 Feb; 6(2):531-5. PubMed ID: 10690535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]